Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries.
This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers who have provided sponsorship towards this independent programme. They have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the marked sponsored symposia. Sessions delivered with input from these organisations are marked as such on the programme. Please see a full list of exhibitors and sponsors here.